Levothyroxine Sodium Tablet
Product Images NDC 51655-727

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 51655-727). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 727 52 Master Bottle Label Approval Rev A 06 21)

Label for levothyroxine sodium tablets, USP 150 mcg, containing 30 oral tablets. It is a prescription drug by Northwind Health Company, LLC. The label includes storage instructions at controlled room temperature, cautions to keep out of reach of children, and protection from moisture and light. The NDC is 51655-727-52.*

FDA Label Image

Levothyroxine-structure (Structure)

Chemical structure diagram of levothyroxine sodium, showing iodine-substituted aromatic rings, hydroxyl and amino groups, and sodium carboxylate with variable hydration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.